MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rec.2017.10.009

Медицинская библиотека · Revista espanola de cardiologia (English ed.) · 2017

Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.

Flores-Blanco Pedro J, Cambronero-Sánchez Francisco, Raposeiras-Roubin Sergio, Abu-Assi Emad, Leithold Gunnar, Cobas-Paz Rafael, Rodríguez Serrano Ana I, Calvo-Iglesias Francisco, Valdés Mariano, Januzzi James L, Iñiguez-Romo Andrés, Manzano-Fernández Sergio

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

INTRODUCTION AND

OBJECTIVES

Acute coronary syndrome (ACS) guidelines recommend the use of newer P2Y12 inhibitors (prasugrel and ticagrelor) over clopidogrel in patients with moderate-to-high ischemic risk, unless they have an increased bleeding risk. The aim of our study was to assess the GRACE risk score and the CRUSADE bleeding risk score relative to prescription of newer P2Y12 inhibitors at discharge in ACS patients.

METHODS

Retrospective analysis of a multicenter ACS registry; 3515 consecutive patients were included. The association between risk scores and prescription of newer P2Y12 inhibitors was assessed by binary logistic regression analysis.

RESULTS

A total of 1021 patients (29%) were treated with prasugrel or ticagrelor. On multivariate analyses, both GRACE (OR per 10 points, 0.89; 95%CI, 0.86-0.92; P < .001) and CRUSADE (OR per 10 points, 0.96; 95%CI, 0.94-0.98; P < .001) risk scores were inversely associated with the use of newer P2Y12 inhibitors. Moreover, other factors not included in these scores (revascularization approach, in-hospital stent thrombosis, major bleeding, and concomitant indication for anticoagulation therapy) also predicted the use of newer P2Y12 inhibitors.

CONCLUSIONS

New P2Y12 inhibitors were more frequently prescribed among ACS patients with lower CRUSADE bleeding risk. However, an ischemic risk paradox was found, with higher use of these agents in patients with lower ischemic risk based on GRACE risk score estimates. These results underscore the importance of risk stratification to safely deliver optimal therapies.

Для цитирования: Flores-Blanco Pedro J, Cambronero-Sánchez Francisco, Raposeiras-Roubin Sergio, Abu-Assi Emad, Leithold Gunnar, Cobas-Paz Rafael, Rodríguez Serrano Ana I, Calvo-Iglesias Francisco, Valdés Mariano, Januzzi James L, Iñiguez-Romo Andrés, Manzano-Fernández Sergio. Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.. Revista espanola de cardiologia (English ed.). 2017. DOI: 10.1016/j.rec.2017.10.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.